Stocks and Investing Stocks and Investing
Fri, May 28, 2021
Thu, May 27, 2021

David Lebowitz Initiated (ARQT) at Buy and Held Target at $52 on, May 27th, 2021


Published on 2024-10-27 16:50:15 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Initiated "Arcutis Biotherapeutics, Inc." (ARQT) at Buy and Held Target at $52 on, May 27th, 2021.

David has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Gregg Gilbert of "Truist Securities" Maintained at Strong Buy with Increased Target to $48 on, Tuesday, February 2nd, 2021
  • Ken Cacciatore of "Cowen & Co." Maintained at Buy with Increased Target to $80 on, Monday, February 1st, 2021
Contributing Sources